Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

South Asian Women & Yoga Education Study (SAWYES)

16 november 2012 uppdaterad av: Dr. Amandah Hoogbruin, Kwantlen Polytechnic University

Yoga for Post-menopausal South Asian Women at Risk for Cardiovascular Disease: A Randomized Control Pilot Study

The purpose of this randomized, control pilot study is to measure the effects of a gentle, 12 week hatha yoga program on post-menopausal, obese, sedentary South Asian women at risk for cardiovascular disease. Hatha yoga is a form of structured physical exercises known as asanas, combined with breathing exercises called pranayama, and relaxation techniques. The yoga intervention consists of 9 different yoga poses (asanas) and 3 different breathing exercises (pranayama) that can be easily replicated and readily performed by individuals who are middle-aged and older, overweight, unfit, or who suffer from a chronic illness.

Studieöversikt

Status

Okänd

Intervention / Behandling

Studietyp

Interventionell

Inskrivning (Förväntat)

50

Fas

  • Fas 1

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

    • British Columbia
      • Surrey, British Columbia, Kanada, V3T 0G9
        • Rekrytering
        • The Jim Pattison Outpatient Care and Surgery Services, Cardiovascular Outpatient Clinic
        • Kontakt:
        • Kontakt:
      • Surrey, British Columbia, Kanada, V3W 2M8
        • Har inte rekryterat ännu
        • Kwantlen Polytechnic University
        • Kontakt:
        • Kontakt:
        • Huvudutredare:
          • Amandah L Hoogbruin, PhD

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

40 år till 65 år (Vuxen, Äldre vuxen)

Tar emot friska volontärer

Ja

Kön som är behöriga för studier

Kvinna

Beskrivning

Inclusion Criteria:

  • 40- 65 years old
  • Postmenopausal (amenorrhea for ≥ 12 months)
  • Overweight as evidenced by a body mass index (BMI) ≥ 25 kg/m2), or waist circumference ≥ 80 cm, or have a first degree relative with diabetes or essential hypertension
  • Sedentary, do not do a regular exercise program (exercising for 20 minutes at sufficient intensity to produce sweating less than 2x/week)
  • Self-identify as a South Asian (sometimes referred to as East Indian in Canada and may be defined "as any person who reports an ethnicity associated with the southern part of Asia or who self-identifies as part of the South Asian visible minority group. This definition encompasses people from a great diversity of ethnic backgrounds, including those with Bangladeshi, Bengali, East Indian, Goan, Gujarati, Hindu, Ismaili, Kashmiri, Nepali, Pakistani, Punjabi, Sikh, Sinhalese, South Asian, Sri Lankan and Tamil ancestry. South Asians may have been born in Canada, on the Indian sub-continent, in the Caribbean, in Africa, in Great Britain or elsewhere
  • Given consent to research protocol and willingness to be randomized to either the treatment (yoga) or control (no yoga) group.

Exclusion Criteria:

  • Have had a period within the last year
  • Are not between the ages of 40 and 65
  • Have experience with yoga within the last 12 months
  • Have any serious disease or condition such as diabetes, serious high blood pressure or heart problems, kidney disease, severe asthma, cancer (except for skin cancer that is not melanoma)
  • Have a major brain or nervous system diagnosis, such as Parkinson's disease or stroke
  • Have a severe infectious or other medical illness right now such as pneumonia
  • Use medications to lower blood sugar levels
  • Have serious back, hip, or neck problems or pain in joints or bones that would prevent the safe completion of a gentle 12 week Hatha yoga program
  • Regularly use an assistive device (e.g., cane, walker) to walk

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Förebyggande
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Enda

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Inget ingripande: Kontrollera
Experimentell: Yoga intervention
12 week 90 minute hatha yoga session offered three (3x) per week. Hatha yoga is a form of structured physical exercises known as asanas, combined with breathing exercises called pranayama, and relaxation techniques. The yoga intervention consists of 9 different yoga poses (asanas) and 3 different breathing exercises (pranayama) that can be easily replicated and readily performed by individuals who are middle-aged and older, overweight, unfit, or who suffer from a chronic illness.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Change in blood pressure
Tidsram: baseline, at end of study (12 wks), & 3 months post-study
blood pressure is measured as a specific physiologic index of cardiovascular risk.
baseline, at end of study (12 wks), & 3 months post-study

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Change in subjective well-being
Tidsram: baseline, at end of study (12 wks), & 3 months post-study
The Perceived Stress Scale and Abbreviated Duke Social Support Index will be used to measure subjective well-being.
baseline, at end of study (12 wks), & 3 months post-study
Change in perceived physical well-being
Tidsram: baseline, end of study (12 wks) & 3 months post-study
Pittsburgh Sleep Quality Index, Physical Activity Scale for the Elderly, and Exercise Regularly Scale will be used to measure change in perceived physical well-being
baseline, end of study (12 wks) & 3 months post-study
Change in insulin sensitivity
Tidsram: baseline, end of study (12 wks) & 3 months post-study
Fasting insulin & glucose will be measured for change in insulin sensitivity as a related index of cardiovascular risk
baseline, end of study (12 wks) & 3 months post-study
Change in inflammation
Tidsram: baseline, end of study (12 wks) & 3 months post-study
C-reactive protein will be measured for change in inflammation as a related index of cardiovascular risk
baseline, end of study (12 wks) & 3 months post-study
Change in serum total cholesterol
Tidsram: baseline, end of study (12 wks) & 3 months post-study
Serum total cholesterol will be measured as a related index of cardiovascular risk
baseline, end of study (12 wks) & 3 months post-study
Change in serum high-density lipoprotein (HDL) cholesterol
Tidsram: baseline, end of study (12 wks) & 3 months post-study
Serum high-density lipoprotein (HDL) cholesterol will be measured as a related index of cardiovascular risk
baseline, end of study (12 wks) & 3 months post-study
Change in serum low-density lipoprotein (LDL) cholesterol
Tidsram: baseline, end of study (12 wks) & 3 months post-study
Serum low-density lipoprotein (LDL)cholesterol will be measured as a related index of cardiovascular risk
baseline, end of study (12 wks) & 3 months post-study
Change in serum triglycerides
Tidsram: baseline, end of study (12 wks) & 3 months post-study
Serum triglycerides will be measured as a related index of cardiovascular risk
baseline, end of study (12 wks) & 3 months post-study
Change in waist circumference.
Tidsram: baseline, end of study (12 wks) & 3 months post-study
Waist circumference will be measured for change in visceral adiposity as a related index of cardiovascular risk
baseline, end of study (12 wks) & 3 months post-study
Change waist-hip ratio
Tidsram: baseline, end of study (12 wks) & 3 months post-study
Waist-hip ratio will be measured for change in visceral adiposity as a related index of cardiovascular risk
baseline, end of study (12 wks) & 3 months post-study
Change in body mass index (BMI)
Tidsram: baseline, end of study (12 wks) & 3 months post-study
Body mass index (BMI) will be measured for change in visceral adiposity as a related index of cardiovascular risk
baseline, end of study (12 wks) & 3 months post-study
Change in resting heart rate
Tidsram: baseline, end of study (12 wks) & 3 months post-study
Resting heart rate will be measured for change in sympathetic activity as a related index of cardiovascular risk
baseline, end of study (12 wks) & 3 months post-study
Change in heart rate
Tidsram: baseline, at end of study (12 wks), & 3 months post-study
Heart rate will be measured for change in sympathetic activity as a related index of cardiovascular risk
baseline, at end of study (12 wks), & 3 months post-study

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Utredare

  • Huvudutredare: Amandah L Hoogbruin, PhD, Kwantlen Polytechnic University

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart

1 november 2012

Primärt slutförande (Förväntat)

1 december 2014

Avslutad studie (Förväntat)

1 augusti 2015

Studieregistreringsdatum

Först inskickad

17 juni 2012

Först inskickad som uppfyllde QC-kriterierna

14 augusti 2012

Första postat (Uppskatta)

17 augusti 2012

Uppdateringar av studier

Senaste uppdatering publicerad (Uppskatta)

19 november 2012

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

16 november 2012

Senast verifierad

1 november 2012

Mer information

Termer relaterade till denna studie

Ytterligare relevanta MeSH-villkor

Andra studie-ID-nummer

  • KK11-04

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera